Mineralys Therapeutics Income Statement (2022-2026) | MLYS

Income Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter) 6.78M5.59M6.06M7.82M12.29M11.88M22.50M23.68M30.75M39.27M53.98M44.57M37.88M38.28M31.45M24.40M24.36M
Selling, General & Administrative (Quarter) 0.79M0.88M1.36M2.19M2.65M3.85M3.77M4.03M4.61M5.89M6.12M7.20M6.57M8.47M9.68M13.88M20.98M
Operating Expenses (Quarter) 7.57M6.48M7.42M10.01M14.94M15.73M26.27M27.71M35.36M45.17M60.11M51.77M44.45M46.75M41.13M38.28M45.34M
Operating Income (Quarter) -7.57M-6.48M-7.42M-10.01M-14.94M-15.73M-26.27M-27.71M-35.36M-45.17M-60.11M-51.77M-44.45M-46.75M-41.13M-38.28M-45.34M
EBIT (Quarter) -7.57M-6.48M-7.42M-10.01M-14.94M-15.73M-26.27M-27.71M-35.36M-45.17M-60.11M-51.77M-44.45M-46.75M-41.13M-38.28M-45.34M
Non-operating items
Interest & Investment Income (Quarter) 0.74M0.94M2.33M3.59M3.51M3.32M3.85M4.15M3.77M2.81M2.24M3.47M4.20M6.04M6.00M
Other Non Operating Income (Quarter) 0.00M0.00M0.00M0.00M0.00M0.00M-0.01M0.01M-0.00M-0.00M0.00M0.00M0.01M
Non Operating Income (Quarter) 0.74M0.94M2.33M3.59M3.32M3.85M4.15M-0.01M-11.77M2.24M3.47M4.20M0.00M6.00M
Net income details
EBT (Quarter) -7.57M-6.48M-6.68M-9.07M-12.61M-12.14M-22.76M-24.39M-31.51M-41.02M-56.33M-48.96M-42.21M-43.27M-36.94M-32.23M-39.34M
Profit After Tax (Quarter) -7.57M-6.48M-6.68M-9.07M-12.61M-12.14M-22.76M-24.39M-31.51M-41.01M-56.34M-48.95M-42.21M-43.27M-36.93M-32.25M-39.34M
Income from Continuing Operations (Quarter) -7.57M-6.48M-6.68M-9.07M-12.61M-12.14M-22.76M-24.39M-31.51M-41.02M-56.33M-48.96M-42.21M-43.27M-36.94M-32.23M-39.34M
Consolidated Net Income (Quarter) -7.57M-6.48M-6.68M-9.07M-12.61M-12.14M-22.76M-24.39M-31.51M-41.02M-56.33M-48.96M-42.21M-43.27M-36.94M-32.23M-39.34M
Income towards Parent Company (Quarter) -7.57M-6.48M-6.68M-9.07M-12.61M-12.14M-22.76M-24.39M-31.51M-41.02M-56.33M-48.96M-42.21M-43.27M-36.94M-32.23M-39.34M
Net Income towards Common Stockholders (Quarter) -7.57M-6.48M-6.68M-9.07M-12.61M-12.14M-22.76M-24.39M-31.51M-41.02M-56.33M-48.96M-42.21M-43.27M-36.94M-32.23M-39.34M
Additional items
EPS (Basic) (Quarter) -1.48-1.26-1.29-1.75-0.51-0.31-0.57-0.63-0.70-0.83-1.13-0.98-0.79-0.66-0.52-0.35-0.47
EPS (Weighted Average and Diluted) (Quarter) -1.48-1.26-1.29-1.75-0.51-0.31-0.57-0.63-0.70-0.83-1.13-0.98-0.79-0.66-0.52-0.35-0.47
Shares Outstanding (Weighted Average) (Quarter) 5.12M5.14M5.18M5.17M24.76M32.30M34.87M36.19M44.90M47.18M48.06M48.54M53.16M65.45M70.59M67.66M82.83M
Shares Outstanding (Diluted Average) (Quarter) 5.12M5.14M5.18M5.17M24.76M39.75M34.87M36.19M44.90M49.36M49.82M48.54M53.16M65.45M63.13M67.66M82.83M
EBITDA (Quarter) -7.57M-6.48M-7.42M-10.01M-14.94M-15.73M-26.27M-27.71M-35.36M-45.17M-60.11M-51.77M-44.45M-46.75M-41.13M-38.28M-45.34M
Shares Outstanding (Quarter) 5.61M5.61M6.42M6.42M40.86M40.86M41.11M41.13M49.63M49.71M49.76M49.82M64.88M65.73M78.97M81.54M82.45M